The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
Novel therapies for the treatment of COVID-19 are continuing to emerge as the SARSCov- 2 pandemic progresses. PCR remains the standard benchmark for initial diagnosis of COVID- 19 infection, while advances in immunological profiling are guiding clinical treatment. The SARSCov- 2 virus has undergo...
Saved in:
Main Author: | Keneth Iceland, Kasozi |
---|---|
Format: | Article |
Published: |
MDPI
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/20.500.12493/532 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections
by: Mohamed, Moubarak, et al.
Published: (2023) -
A descriptive-multivariate analysis of community knowledge, confidence, and trust in COVID-19 clinical trials amongst Ugandans working in healthcare settings.
by: Keneth Iceland, Kasozi, et al.
Published: (2021) -
COVID-19-related stress, anxiety and vaccine hesitancy among healthcare workers in a tertiary hospital in South-Western Nigeria
by: Temitope Olumuyiwa Ojo, et al.
Published: (2025-02-01) -
Immunologic and inflammatory consequences of SARS-CoV-2 infection and its implications in renal disease
by: Hiam Naiditch, et al.
Published: (2025-02-01) -
Registered COVID deaths in South Africa during the first year of the SARS-CoV-2 epidemic
by: T A Moultrie, et al.
Published: (2024-08-01)